UBS Group’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.51M | Sell |
|
|||||
|
2025
Q2 | $6.86M | Sell |
|
|||||
|
2025
Q1 | $14.4M | Buy |
|
|||||
|
2024
Q4 | $10.9M | Buy |
|
|||||
|
2024
Q3 | $6.15M | Buy |
|
|||||
|
2024
Q2 | $4.25M | Buy |
|
|||||
|
2024
Q1 | $2.33M | Buy |
|
|||||
|
2023
Q4 | $764K | Buy |
|
|||||
|
2023
Q3 | $289K | Buy |
|
|||||
|
2023
Q2 | $44.9K | Buy |
|
|||||
|
2023
Q1 | $26.2K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $23K | Sell |
|
|||||
|
2021
Q3 | $44K | Buy |
|